BIOTRONIK Demonstrates Ongoing Commitment to Advancing Scientific Knowledge at HRS
Retrieved on:
Friday, June 23, 2023
Insurance, Database, Arrhythmia, Mayo Clinic, Di Biase, Heart failure, Vaccination, Effect, Wildfire, COVID-19, ATP, ICD, Stanford University, Research, History, VF, Physical, Medicare, US, Heart Rhythm, Ventricular tachycardia, Patient, Physician, DX, Stanford University School of Medicine, Albert Einstein College of Medicine, Air pollution, Pharmaceutical industry, S81
LAKE OSWEGO, Ore., June 23, 2023 /PRNewswire/ -- Continuing a history of commitment to furthering research in its field, four studies supported by BIOTRONIK's real-world evidence generating research initiative, CERTITUDE, were presented at Heart Rhythm 2023 on May 20th and 21st.
Key Points:
- The CERTITUDE registry, established in 2020, is a comprehensive source of real-world data gathered from BIOTRONIK Home Monitoring®, device tracking, and insurance claims data from qualifying US BIOTRONIK patients.
- This data is made available for physicians to leverage through submission and approval of a research proposal.
- Results from two other CERTITUDE analyses highlighted BIOTRONIK products, features and their corresponding benefits for patients and clinicians.
- Leveraging a natural experiment to determine the effect of air pollution on ventricular arrhythmias and physical activity: The 2020 U.S. wildfires.